Pediatrix Medical Group, Inc.
US ˙ NYSE ˙ US58502B1061

SecurityMD / Pediatrix Medical Group, Inc.
InstitutionMan Group plc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Man Group plc closes position in MD / Pediatrix Medical Group, Inc.

On November 14, 2025 - Man Group plc filed a 13F-HR form disclosing ownership of 0 shares of Pediatrix Medical Group, Inc. (US:MD) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 38,524 shares of Pediatrix Medical Group, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 0 -100.00 0
2025-08-14 2025-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 38,524 38,524 553 0.0011
2022-05-16 2022-03-31 13F MEDNAX COM 58502B106 0 -52,583 -100.00 0 -100.00
2022-02-14 2021-12-31 13F MEDNAX COM 58502B106 52,583 -12,865 -19.66 1,431 -23.11 0.0046
2021-11-15 2021-09-30 13F MEDNAX COM 58502B106 65,448 -5,562 -7.83 1,861 -13.08 0.0065
2021-08-16 2021-06-30 13F MEDNAX COM 58502B106 71,010 4,801 7.25 2,141 26.99 0.0075
2021-05-17 2021-03-31 13F MEDNAX COM 58502B106 66,209 66,209 1,686 0.0074
2020-05-15 2020-03-31 13F MEDNAX COM 58502B106 0 -347,877 -100.00 0 -100.00
2020-02-18 2019-12-31 13F MEDNAX COM 58502B106 347,877 -83,913 -19.43 9,668 -1.01 0.0318
2019-11-14 2019-09-30 13F MEDNAX COM 58502B106 431,790 213,629 97.92 9,767 77.45 0.0363
2019-08-14 2019-06-30 13F MEDNAX COM 58502B106 218,161 126,987 139.28 5,504 122.11 0.0199
2019-05-15 2019-03-31 13F MEDNAX COM 58502B106 91,174 -97,091 -51.57 2,478 -60.11 0.0094
2019-02-14 2018-12-31 13F MEDNAX COM 58502B106 188,265 -340,492 -64.39 6,212 -74.82 0.0276
2018-11-14 2018-09-30 13F MEDNAX COM 58502B106 528,757 194,334 58.11 24,672 70.46 0.0901
2018-08-14 2018-06-30 13F MEDNAX COM 58502B106 334,423 184,748 123.43 14,474 73.84 0.0595
2018-05-15 2018-03-31 13F MEDNAX COM 58502B106 149,675 149,675 8,326 0.0381
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.